Document is current
Any future updates will be listed below
-
Authors
Kandiyali, Rebecca http://orcid.org/0000-0001-8566-9536
Thom, Howard
Young, Amber E.
Greenwood, Rosemary
Welton, Nicky J.
-
Funding
Funding for this research was provided by:
Medical Research Council (MR/K025643/1)
Research for Patient Benefit Programme (PB-PG-0214-33003)
Scar Free Foundation
- License Information
-
More Information
Article History
Received: 5 June 2019
Accepted: 17 December 2019
First Online: 31 January 2020
Ethics approval and consent to participate
: This model is secondary research, however, the before and after study which provided the absolute and relative risks for the model had the ethical approval from The National Institute for Social Care and Health Research Ethics Service Committee Wales REC 4 (REC reference: 15/WA/0156).
: Not applicable.
: The authors declare no competing interests. HT reports personal fees for consultancy work from Pfizer, Novartis Pharma, Hoffman La-Roche, Bayer, Janssen, and Eli Lilly and company, all outside this work.
